Cholinesterase inhibitors and memantine for Parkinson's disease dementia and Lewy body dementia: A meta-analysis

Recently, several randomized controlled trials on the use of cholinesterase inhibitors or memantine as treatments for cognitive impairment in Parkinson's disease (CIND-PD), Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB) were completed. The present study provide...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Yan-Hong, Wang, Pan-Pan, Song, Ya-Xue, Wang, Jian-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364145/
https://www.ncbi.nlm.nih.gov/pubmed/30783428
http://dx.doi.org/10.3892/etm.2018.7129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364145/
https://www.ncbi.nlm.nih.gov/pubmed/30783428
http://dx.doi.org/10.3892/etm.2018.7129

Ejemplares similares